Evidence map›Paper›PMID 26025465›Full record

ArticleCardiovascular diabetology2015

Low 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 levels are independently associated with macroalbuminuria, but not with retinopathy and macrovascular disease in type 1 diabetes: the EURODIAB prospective complications study.

Lian Engelen, Casper G Schalkwijk, Simone J P M Eussen, Jean L J M Scheijen, Sabita S Soedamah-Muthu, Nish Chaturvedi, John H Fuller, Coen D A Stehouwer

Open access · goldAbstract read
In one paragraph

Article in Cardiovascular diabetology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 56 citations in OpenAlex.

  1. Vitamin D and Ocular Diseases: A Systematic Review.International journal of molecular sciences · 2022
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Observational
  7. Article
  8. Article
  9. Article
  10. Article
  11. Determinants of Vitamin D Supplementation among Individuals with Type 1 Diabetes.International journal of environmental research and public health · 2020
    Article
  12. Article
  13. Article
  14. Vitamin D and diabetes mellitus: Causal or casual association?Reviews in endocrine & metabolic disorders · 2017
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Vitamin D and Diabetic Complications: True or False Prophet?Diabetes therapy : research, treatment and education of diabetes and related disorders · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Lian EngelenDepartment of Internal Medicine, Maastricht University Medical Centre, Universiteitssingel 50, 6200 MD, Maastricht, The Netherlands. l.engelen@maastrichtuniversity.nl.
Casper G SchalkwijkDepartment of Internal Medicine, Maastricht University Medical Centre, Universiteitssingel 50, 6200 MD, Maastricht, The Netherlands. c.schalkwijk@maastrichtuniversity.nl.
Simone J P M EussenCAPHRI School for Public Health and Primary Care, Maastricht University Medical Centre, Maastricht, The Netherlands. simone.eussen@maastrichtuniversity.nl.
Jean L J M ScheijenDepartment of Internal Medicine, Maastricht University Medical Centre, Universiteitssingel 50, 6200 MD, Maastricht, The Netherlands. j.scheijen@maastrichtuniversity.nl.
Sabita S Soedamah-MuthuDivision of Human Nutrition, Wageningen University, Wageningen, The Netherlands. sabita.soedamah-muthu@wur.nl.
Nish ChaturvediInternational Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London, London, UK. n.chaturvedi@ucl.ac.uk.
John H FullerDepartment of Epidemiology and Public Health, University College, London, UK. johnfuller211@btinternet.com.
Coen D A StehouwerDepartment of Internal Medicine, Maastricht University Medical Centre, Universiteitssingel 50, 6200 MD, Maastricht, The Netherlands. cda.stehouwer@mumc.nl.
Maastricht University Medical Centre · NLMaastricht University · NLUniversity College London · GBWageningen University & Research · NL

Funding

Wellcome Trust
6 · The paper itself

Abstract

backgroundLow circulating levels of total vitamin D [25(OH)D] and 25(OH)D3 have been associated with vascular complications in few studies on individuals with type 1 diabetes. However, these measures are affected by UV light exposure. Circulating 25(OH)D2, however, solely represents dietary intake of vitamin D2, but its association with complications of diabetes is currently unknown. We investigated the associations between 25(OH)D2 and 25(OH)D3 and the prevalence of albuminuria, retinopathy and cardiovascular disease (CVD) in individuals with type 1 diabetes.

methodsWe measured circulating 25(OH)D2 and 25(OH)D3 in 532 individuals (40 ± 10 years old, 51 % men) with type 1 diabetes who participated in the EURODIAB Prospective Complications Study. Cross-sectional associations of 25(OH)D2 and 25(OH)D3 with albuminuria, retinopathy and CVD were assessed with multiple logistic regression analyses adjusted for age, sex, season, BMI, smoking, HbA1c, total-HDL-cholesterol-ratio, systolic blood pressure, antihypertensive medication, eGFR, physical activity, alcohol intake, albuminuria, retinopathy and CVD, as appropriate.

resultsFully adjusted models revealed that 1 nmol/L higher 25(OH)D2 and 10 nmol/L higher 25(OH)D3 were associated with lower prevalence of macroalbuminuria with ORs (95 % CI) of 0.56 (0.43;0.74) and 0.82 (0.72;0.94), respectively. These vitamin D species were not independently associated with microalbuminuria, non-proliferative and proliferative retinopathy or CVD.

conclusionsIn individuals with type 1 diabetes, both higher 25(OH)D2 and 25(OH)D3 are associated with a lower prevalence of macroalbuminuria, but not of retinopathy and CVD. Prospective studies are needed to further examine the associations between 25(OH)D2 and 25(OH)D3 and the development of microvascular complications and CVD in type 1 diabetes.

Indexed as

25-Hydroxyvitamin D 2AdultAlbuminuriaCalcifediolCardiovascular DiseasesCohort StudiesCross-Sectional StudiesDiabetes Mellitus, Type 1Diabetic AngiopathiesDiabetic RetinopathyFemaleHumansLogistic ModelsMaleMiddle AgedProspective Studies25-Hydroxyvitamin D 2Calcifediol

Identifiers

PMID26025465
PMCPMC4456046
OpenAlexW2104493239

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.